C. Richard Piazza has been appointed chief executive officer of Chemokine Therapeutics Corp. Mr. Piazza succeeds Dr. Hassan Salari who held the position since he founded the company in 1998. Dr. Salari will continue to serve as president and his role will be expanded to include the additional responsibilities as the chief scientific officer. These changes will allow Dr. Salari to focus on the company’s product development while Mr. Piazza will use his financial and biotechnology industry e...